OPKO Health, Inc. (OPK)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$1.21
+0.83%
Mkt Cap $936.60M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $139.76M | $148.50M | +6.26% | -$0.07 | -$0.04 | +42.86% | — | — |
| Q4 2025 Oct 29, 2025 | $139.76M | $151.67M | +8.52% | -$0.02 | $0.03 | +250.00% | — | — |
| Q3 2025 Jul 31, 2025 | $165.74M | $156.81M | -5.39% | -$0.12 | -$0.19 | -58.33% | — | — |
| Q2 2025 Apr 30, 2025 | $165.70M | $149.95M | -9.50% | -$0.06 | -$0.10 | -66.67% | — | — |
| Q1 2025 Feb 27, 2025 | $155.42M | $183.64M | +18.16% | -$0.08 | $0.01 | +112.50% | — | — |
| Q4 2024 Nov 7, 2024 | $155.42M | $173.63M | +11.72% | -$0.10 | $0.03 | +130.00% | — | — |
| Q3 2024 Aug 7, 2024 | $185.19M | $182.19M | -1.62% | -$0.09 | -$0.01 | +88.89% | — | — |
| Q2 2024 May 7, 2024 | $182.99M | $173.69M | -5.08% | -$0.09 | -$0.12 | -33.33% | — | — |
| Q1 2024 Feb 27, 2024 | $177.53M | $181.90M | +2.46% | -$0.09 | -$0.09 | +0.00% | — | — |
| Q4 2023 Nov 6, 2023 | $174.78M | $178.60M | +2.19% | -$0.09 | -$0.11 | -22.22% | — | — |
| Q3 2023 Aug 3, 2023 | $182.53M | $265.42M | +45.41% | -$0.07 | -$0.03 | +57.14% | — | — |
| Q2 2023 May 3, 2023 | $193.35M | $237.60M | +22.89% | -$0.07 | -$0.02 | +71.43% | — | — |
| Q1 2023 Feb 23, 2023 | $168.21M | $185.40M | +10.22% | -$0.11 | -$0.11 | +0.00% | — | — |
| Q4 2022 Nov 8, 2022 | $183.51M | $179.74M | -2.05% | -$0.10 | -$0.11 | -10.00% | — | — |
| Q3 2022 Aug 4, 2022 | $326.87M | $309.89M | -5.19% | -$0.00 | -$0.04 | -1851.22% | — | — |
| Q2 2022 May 9, 2022 | $332.62M | $329.22M | -1.02% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q1 2022 Feb 24, 2022 | $329.83M | $401.30M | +21.67% | -$0.02 | -$0.11 | -450.00% | — | — |
| Q4 2021 Oct 28, 2021 | $298.82M | $385.81M | +29.11% | $0.02 | $0.04 | +100.00% | — | — |
| Q3 2021 Jul 29, 2021 | $442.41M | $442.41M | +0.00% | -$0.01 | -$0.03 | -155.54% | — | — |
| Q2 2021 Apr 28, 2021 | $498.92M | $545.16M | +9.27% | $0.05 | $0.05 | +0.00% | — | — |